The report “Global Molecular Diagnostics Market” provides an in-depth analysis. For more mail: vikas@konceptanalytics.com

1. Global Molecular Diagnostics Market
-----------------------------------------
2015
View Report Details

2. Executive Summary
Molecular diagnostics is a dynamic and transformative area of diagnostics, leading to insights in research and treatment in many disease states that
are revolutionizing health care. Molecular diagnostics detects and measures the presence of genetic material or proteins associated with a specific
health condition or disease, helping to uncover the underlying mechanisms of disease and enabling clinicians to tailor care at an individual level
facilitating the practice of personalized medicine.
Molecular diagnostics today is routinely used in hospitals, reference labs, and blood banks. In the latter, molecular tests are used to screen donated
blood products for infectious diseases like hepatitis and HIV. In hospitals, testing is often performed to identify pathogens in patients with infections.
In fact, infectious diseases are one of the strongest growing areas within the molecular diagnostics field. There is also increasing demand for such
technologies at the point of care.
The report “Global Molecular Diagnostics Market” provides an in-depth analysis of the molecular diagnostics market along with a detailed study of its
various segments. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The four major
players in the industry, Roche Holding AG, Qiagen NV, Abbott Laboratories and Novartis are being profiled.
The key factors driving the growth of the molecular diagnostics industry are rising incidence of chronic and infectious disease, rising awareness and
acceptance of personalized medicine, expansion in emerging countries, ageing population and technological developments. Some of the noteworthy
trend and developments of this industry are growth of next generation sequencing and growth in point of care diagnostics. However, the expansion
of global molecular diagnostics industry is hindered by challenges in genetic diagnostics and regulatory issues.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry.
We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the
future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the
dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
View Report Details

3. The key factors driving the growth of the molecular diagnostics industry are rising incidence of chronic
and infectious disease, rising awareness and acceptance of personalized medicine and growing global
economy.
 As of 2014, the global IVD market was recorded at US$...
billion, as compared to US$… billion in 2013, showing an incline
of …%. The global IVD market is anticipated to reach US$...
billion by 2016.
 The global market for molecular diagnostics was recorded at
US$.... billion in 2014, as compared to US$.... billion in 2013.
The market registered a robust CAGR of …% during the period
spanning 2009-2014.
 Defining the market by segments, the Infectious Diseases
account for …% of the total molecular diagnostics market,
followed by Oncology and Hematology segment with its share of
…%
Global Molecular Diagnostics Market (2009-2014)
Global IVD Market (2011-2016E)
Molecular Diagnostics Market Share by Segment (2014)
2011 2012 2013 2014 2015E 2016E
US$Billion
2009 2010 2011 2012 2013 2014
US$Billion

4. The key factors driving the growth of the molecular diagnostics industry are rising incidence of chronic
and infectious disease, rising awareness and acceptance of personalized medicine and growing global
economy.
 In terms of volume, the global HPV market was recorded at …
units in 2014, as compared to …. units in 2013, depicting an
incline of …%.
 In terms of volume, the CT/NG market has been showing a
gradual uptrend in recent years. In 2014, the CT/NG market
reached … units, growing by …%, as compared to… units in
2013.
 The market of genetic testing reached US$... billion in 2014, as
compared to US$… billion in 2013, depicting an incline of …%.
Global CT/NG Market by Volume (2011-2015E)
Global HPV Market by Volume (2010-2014)
Global Genetic Testing Market (2007-2014)
2010 2011 2012 2013 2014
MillionUnits
2011 2012 2013 2014 2015E
MillionUnits
2007 2008 2009 2010 2011 2012 2013 2014
US$Billion

5. Economic development, rising healthcare expenditure, rising incidence of HPV disease, growing Point-of-
Care diagnostics are the chief factors that will drive the market…
• The global demand of molecular diagnostics is poised to grow at compounded annual growth rate of …% from US$... billion in
2014 to US$... billion in 2018.
• The economic growth of a country leads to an increase in wealth, thereby contributing in the growth of respective market.
• Growing demand for personalized medicine and the subsequent introduction of advanced cancer diagnostic technologies leads to
the demand of molecular diagnostics market.
• The future growth would mainly be driven by the growth of next generation sequencing, growth in point of care diagnostics and
global GDP.
Global Molecular Diagnostics Market Forecast (2014-2018E)
2014 2015E 2016E 2017E 2018E
US$Billion

6. Koncept Analytics
CS-36, Second Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T. +91-120-4130959
C: +91-9811715635
vikas@konceptanalytics.com
Contact Us:
www.konceptanalytics.com
Vikas Gupta
BD Manager
These are abridged and sanitized sample pages from the comprehensive report on the “ Global Molecular Diagnostics
Market ”. To know more about this report or for any customized research requirement, please contact the following:
View Report Details